BETA
BETA
Amphastar Pharmaceuticals
AMPH89
$42.48arrow_drop_up0.80%$0.34
High Quality
AMPH89
$42.48
arrow_drop_up0.80%Performance History
| Key Stats | |
|---|---|
| Open | $41.40 |
| Prev. Close | $41.19 |
| EPS | 2.91 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 41.31 | 42.56 |
| 52 Week Range | 36.56 | 67.66 |
| Ratios | |
|---|---|
| EPS | 2.91 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About Amphastar Pharmaceuticals (AMPH)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Dr. Yongfeng Zhang Ph.D.
- Headquarters
- Rancho Cucamonga
- Employees
- 1615
- Exchange
- NASDAQ
Keep an eye on Amphastar Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Amphastar Pharmaceuticals 's (AMPH) price per share?
The current price per share for Amphastar Pharmaceuticals (AMPH) is $42.48. The stock has seen a price change of $0.34 recently, indicating a 0.81% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Amphastar Pharmaceuticals (AMPH)?
For Amphastar Pharmaceuticals (AMPH), the 52-week high is $67.66, which is 59.27% from the current price. The 52-week low is $36.56, the current price is 16.19% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Amphastar Pharmaceuticals (AMPH) a growth stock?
Amphastar Pharmaceuticals (AMPH) has shown an average price growth of 0.41% over the past three years. It has received a score of 90 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Amphastar Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Amphastar Pharmaceuticals (AMPH) stock price performance year to date (YTD)?
As of the latest data, Amphastar Pharmaceuticals (AMPH) has a year-to-date price change of -31.8%. Over the past month, the stock has experienced a price change of 4.68%. Over the last three months, the change has been 4.04%. Over the past six months, the figure is -20.21%. Looking at a longer horizon, the five-year price change stands at 114.44%.
help
Is Amphastar Pharmaceuticals (AMPH) a profitable company?
Amphastar Pharmaceuticals (AMPH) has a net income of $137.54M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 53.38% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 27.94% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $644.4M, with a revenue growth rate of 29.14%, providing insight into the company's sales performance and growth. The gross profit is $343.97M. Operating income is noted at $199.69M. Furthermore, the EBITDA is $269.38M.
help
What is the market capitalization of Amphastar Pharmaceuticals (AMPH)?
Amphastar Pharmaceuticals (AMPH) has a market capitalization of $2.08B. The average daily trading volume is 344K, indicating the stock's liquidity and investor engagement.
News
HCA HEALTHCARE
Q2 2024 EARNINGS
HEALTHCARE
HOSPITAL OPERATOR
7/23/2024HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2024 EPS View - Zacks Investment Research
5/30/2024
Amphastar Pharmaceuticals: Buy When Fear Is Overblown
5/15/2024
Implied Volatility Surging for Amphastar (AMPH) Stock Options
5/8/2024
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
5/2/2024
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
5/1/2024
Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.